Sumita Ray

Sumita Ray

Compliance Officer at CUE BIOPHARMA, INC.

Net worth: 1 M $ as of 2026-05-30

52 year
Health Technology
Consumer Services

Profile

Sumita Ray is currently Independent Director at Biomea Fusion, Inc. since 2021, Chief Legal & Administrative Officer at Vaxxinity, Inc. since 2023, Principal at Fifthray Consulting LLC since 2015, and Secretary, Chief Legal & Compliance Officer at Cue Biopharma, Inc. starting in 2026.
Former roles include Corporate Counsel at Genentech, Inc. from 2007 to 2010, Chief Compliance Officer at Pharmacyclics LLC, Head-BioNeurology & Regulatory Law Group at Elan Pharmaceuticals LLC from 2010 to 2013, Counsel at AstraZeneca LP from 2005 to 2007, Chief Compliance Officer, SVP & General Counsel at Calithera Biosciences, Inc. from 2017 to 2022, Chief Legal, Compliance & Administrative Officer at Instil Bio, Inc. from 2022 to 2023, and Chief Compliance Officer at Pharmacyclics, Inc. Education includes undergraduate studies at the University of Arizona and graduate studies at Temple University Beasley School of Law.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-31 54,589 ( 1.35% ) 1 M $ 2026-05-30
2026-06-09 0 ( -.--% ) - $ 2026-05-30

Sumita Ray active positions

CompaniesPositionStart
BIOMEA FUSION, INC. Director/Board Member 2021-06-15
VAXXINITY, INC. Chief Administrative Officer 2023-09-30
CUE BIOPHARMA, INC. Compliance Officer 2026-05-31

Former positions of Sumita Ray

CompaniesPositionEnd
INSTIL BIO, INC. Chief Administrative Officer 2023-05-08
CALITHERA BIOSCIENCES, INC. Chief Administrative Officer 2022-03-31
Compliance Officer 2015-04-30
Corporate Officer/Principal 2013-03-31
General Counsel 2010-04-30
See the detail of Sumita Ray's experience

Training of Sumita Ray

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

82

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology